Lymphatic Filariasis

Organisms/Vector

W. bancrofti (~90% global cases, dominant in India), B. malayi, B. timori. Vector: W. bancrofti = Culex quinquefasciatus (urban India, polluted water breeding). Brugia = Mansonia (aquatic vegetation breeding). Adults: long thread-like, coiled in lymphatics/nodes. Females release LIVE MICROFILARIAE (not eggs) into blood.

Life Cycle / Nocturnal Periodicity

Bite → larvae → lymphatics → adult worms (months to mature, live years in afferent lymphatics/nodes) → microfilariae in peripheral blood → picked up by mosquito → infective stage develops IN MOSQUITO (not further in human).

NOCTURNAL PERIODICITY (W. bancrofti + most Brugia): microfilariae ABSENT from peripheral blood by day (sequester in pulmonary capillaries) → SURGE at night (peak ~10pm-2am), matching vector night-biting. → blood collection for microfilaria detection = SCHEDULED AT NIGHT.

Pathogenesis/Clinical

Mechanism: mechanical damage (live/dead worms) + chronic inflammation + HOST IMMUNE RESPONSE (contributes MORE to chronic disease than parasite presence alone).

Asymptomatic microfilaremia = COMMONEST state in endemic areas. Subclinical lymphatic damage often present despite no symptoms.

Acute filariasis: recurrent ADL (adenolymphangitis) — fever + painful inflamed nodes + lymphangitis (red tender cord-like streak). Often triggered by 2° bacterial infection via skin breaks.

Chronic filariasis (years of damage):

Hydrocele — COMMONEST chronic manifestation, W. BANCROFTI ONLY (spermatic cord lymphatics). Brugia does NOT cause genital disease.
Lymphoedema
Elephantiasis — end-stage, thickened fibrotic hyperkeratotic skin, massive limb/scrotum swelling. Most visually recognizable.
Chyluria — lymphatic-urinary communication, milky urine.

Tropical Pulmonary Eosinophilia (TPE): distinct HYPERSENSITIVITY syndrome. Nocturnal cough/wheeze/breathlessness + marked eosinophilia + very high IgE. Microfilariae trapped/destroyed in pulmonary capillaries. KEY: microfilariae ABSENT from peripheral blood in TPE despite clear filarial trigger (sequestered/destroyed in lungs).

Laboratory Diagnosis

Microscopy: thick blood film (Giemsa/hematoxylin), NIGHT collection. Species by tail-tip nuclei:

W. bancrofti: sheathed, tapering tail, NO terminal nuclei
Brugia: sheathed, TWO distinct terminal nuclei Concentration (membrane filtration, Knott’s) for low density.

Antigen detection: ICT (circulating W. bancrofti adult worm antigen). MAJOR ADVANCE — NOT restricted to night collection, detects infection even in AMICROFILAREMIC individuals (microscopy limitation).

Ultrasound: “filarial dance sign” — live motile adult worms visible in dilated scrotal/limb lymphatics.

Serology: antifilarial Ab, limited by cross-reactivity with other helminths.

Treatment

DEC (diethylcarbamazine) = traditional mainstay, kills microfilariae + some adult worm effect.

Albendazole (combo with DEC; combo with IVERMECTIN if onchocerciasis co-endemic — DEC avoided there, severe reaction risk). Established chronic lymphoedema/elephantiasis: NOT reversed by antifilarial drugs. Management = lymphoedema care (hygiene, compression, elevation) + surgery for hydrocele.

Prevention — MDA

India National Filaria Elimination Programme + WHO Global Programme. Mass Drug Administration: single-dose DEC+albendazole, ENTIRE at-risk population (regardless of infection status), annual, endemic districts, several years — suppresses community microfilarial reservoir below transmission threshold.

Vector control + morbidity management (lymphoedema care, hydrocelectomy).

The Organisms and Vector

Lymphatic filariasis is caused by three closely related filarial nematodes — Wuchereria bancrofti (responsible for roughly 90% of global cases, and the dominant species across India), Brugia malayi, and Brugia timori — all transmitted by mosquito bite. W. bancrofti is spread mainly by Culex quinquefasciatus in urban/semi-urban India (breeding in polluted water), while Brugia species are transmitted chiefly by Mansonia mosquitoes (breeding on aquatic vegetation). Adult worms are long, thread-like, and live coiled in the lymphatics and lymph nodes; females release live microfilariae directly into blood rather than eggs.

Life Cycle and Nocturnal Periodicity

An infective mosquito bite deposits larvae that migrate to lymphatics and mature into adult worms over months, living in afferent lymphatics and lymph nodes for years. Mated adults produce microfilariae that circulate in peripheral blood, ready to be picked up by a feeding mosquito to continue transmission (development to the infective stage occurs within the mosquito, not further in humans).

A genuinely distinctive and clinically exploited feature of W. bancrofti and most Brugia strains is nocturnal periodicity: microfilariae are essentially absent from peripheral blood during the day, sequestering in deep pulmonary capillaries, and surge into peripheral circulation at night (peak roughly 10 pm–2 am) — timed to coincide with the nocturnal biting habit of the Culex/Mansonia vectors. This is why blood collection for microfilaria detection is deliberately scheduled for the night.

Pathogenesis and Clinical Manifestations

Disease results from a combination of direct mechanical lymphatic damage by living/dead adult worms, chronic lymphatic inflammation, and — importantly — the host’s own immune/inflammatory response, which contributes more to the chronic disease burden than the parasite’s mere physical presence.

Asymptomatic microfilaraemia is actually the commonest state in endemic populations — many infected individuals carry circulating microfilariae for years with no overt symptoms, though subclinical lymphatic damage is often already present on imaging.

Acute filariasis presents as recurrent episodes of adenolymphangitis (ADL) — fever with painful, inflamed lymph nodes and lymphangitis (a red, tender, cord-like streak along an inflamed lymphatic, often affecting a limb), typically triggered or worsened by secondary bacterial infection through skin breaks in an already-damaged limb.

Chronic filariasis develops after years of repeated lymphatic damage: hydrocele (the commonest chronic manifestation of W. bancrofti specifically, from spermatic cord lymphatic involvement — Brugia species do not cause genital disease), lymphoedema, and its end-stage, elephantiasis — grossly thickened, fibrotic, hyperkeratotic skin over a massively swollen limb or scrotum, the disease’s most visually recognizable and disabling manifestation. Chyluria (lymphatic fluid leaking into urine, causing milky urine) reflects lymphatic-urinary tract communication.

Tropical pulmonary eosinophilia (TPE) is a distinct hypersensitivity syndrome — nocturnal cough, wheeze, and breathlessness with marked peripheral eosinophilia and very high IgE, occurring in a small subset of infected individuals as an exaggerated immune response to microfilariae trapped in pulmonary capillaries; classically, microfilariae are notably absent from peripheral blood in TPE despite the clear filarial trigger, since they’re sequestered and destroyed in the lungs rather than circulating.

Laboratory Diagnosis

Microscopy: thick blood film (Giemsa or haematoxylin stain) collected at night (per the periodicity described above) demonstrating microfilariae directly — species differentiated by the presence/absence and arrangement of nuclei in the tail tip (W. bancrofti: sheathed, tail tapering, no terminal nuclei; Brugia: sheathed, two distinct terminal nuclei). Concentration techniques (membrane filtration, Knott’s concentration) improve sensitivity for low microfilarial density.

Antigen detection: immunochromatographic card tests (ICT) detecting circulating W. bancrofti adult worm antigen — a major diagnostic advance since antigen tests, unlike microscopy, are not restricted to nocturnal collection and detect infection even in amicrofilaraemic individuals (a real limitation of microscopy, since chronic disease and even active infection can occur without demonstrable circulating microfilariae).

Ultrasound (“filarial dance sign”) can directly visualize live, motile adult worms within dilated scrotal or limb lymphatics — a distinctive, specific finding.

Serology (antifilarial antibody) has a role but is limited by cross-reactivity with other helminth infections.

Treatment

Diethylcarbamazine (DEC) is the traditional mainstay, effective against microfilariae and to a lesser extent adult worms. Albendazole is typically combined with DEC (or with ivermectin in areas co-endemic with onchocerciasis, where DEC is avoided due to severe reaction risk) for enhanced efficacy, particularly in mass drug administration programmes. Established chronic lymphoedema/elephantiasis is not reversed by antifilarial drugs — management shifts to lymphoedema care (limb hygiene, compression, elevation) and surgical intervention for hydrocele.

Prevention: Mass Drug Administration (MDA)

India’s National Filaria Elimination Programme, aligned with the WHO Global Programme to Eliminate Lymphatic Filariasis, relies on annual mass drug administration — single-dose DEC plus albendazole given to the entire at-risk population (regardless of individual infection status) in endemic districts, repeated annually for several years to interrupt transmission by suppressing the community-wide microfilarial reservoir below the threshold needed to sustain mosquito transmission. This is combined with vector control and morbidity management (lymphoedema care, hydrocelectomy) for those already affected.